Navigation Links
Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
Date:8/10/2011

lease contains forward-looking statements, which are subject to certain risks and uncertainties that can cause actual results to differ materially from those described. Factors that may cause such differences include, but are not limited to, uncertainties relating to the time required to build inventory and establish commercial operations in Europe, adoption, use and resulting sales, if any, for the Hepatic CHEMOSAT delivery system in the EEA, our ability to successfully commercialize the chemosaturation system and the potential of the chemosaturation system as a treatment for patients with terminal metastatic disease in the liver, acceptability of the Phase III clinical trial data by the FDA, our ability to address the issues raised in the Refusal to File letter received from the FDA and the timing of our re-submission of our NDA, re-submission and acceptance of the Company's NDA by the FDA, approval of the Company's NDA for the treatment of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the United States, approval of the current or future chemosaturation system for other indications, actions by the FDA or other foreign regulatory agencies, our ability to obtain reimbursement for the CHEMOSAT system, our ability to successfully enter into distribution and strategic partnership agreements in foreign markets and the corresponding revenue associated with such foreign markets, uncertainties relating to the results of research and development projects and future clinical trials, and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statem
'/>"/>
SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Delcath Systems to Report Second Quarter Progress Update and Conduct Conference Call
2. Delcath Systems, Inc. Announces the Completion of Common Stock Offering
3. Delcath Systems, Inc. Announces the Sale of 5,000,000 Shares of Common Stock
4. Delcath on Preliminary List of Additions to Russell Microcap® Index
5. Delcath to Present at the JMP Securities Research Conference
6. Delcath Names Harold C. Mapes as Executive Vice President of Global Operations
7. Delcath Receives Notice of European Regulatory Approval for Hepatic CHEMOSAT™ Delivery System
8. Delcath to Update Investors on FDA Meeting
9. Delcath Expands Board of Directors With Appointment of Gabriel Leung
10. Delcath to Present at Upcoming Investor Conferences
11. Delcath Systems Receives Refusal to File Letter From FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... -- Zimmer Holdings, Inc. (NYSE: ZMH and ... and organizational structure of the combined company following the ... the combined organization will leverage the strength of both ... the new brand to be rolled out across the ... future leadership team is committed to establishing Zimmer Biomet ...
(Date:10/30/2014)... Oct. 30, 2014   ViaDerma, Inc. ... bringing new products to market, has recently released ... TetraStem is a topical liquid tetracycline-based antibiotic that ... can convert oral medication active ingredients into topical ... first aid antibiotic to help prevent skin infection ...
(Date:10/30/2014)... SAN FRANCISCO , Oct. 30, 2014  Nektar ... financial results for the third quarter ended September 30, ... of U.S.-based financial markets. Howard Robin , president ... to review the results beginning at 5:00 p.m. Eastern ... The press release and a live audio-only Webcast of ...
Breaking Medicine Technology:Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 2Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 3Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 4Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 5Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 6Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 7Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 8Zimmer Announces Executive Leadership Team and New Name of Combined Company Following Closing 9ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3Nektar to Announce Financial Results for the Third Quarter 2014 on Thursday, November 6, 2014, After Close of U.S.-Based Financial Markets 2
... Board: CONX ), a worldwide developer and marketer ... 10-K and reported financial results. The report disclosed that the ... June 30, 2010. Some of the results highlighted by the ... year was $815,981 vs. $403,741 for the prior year. ...
... Inc. (Nasdaq: BMRN ) announced today the appointment ... Board of Directors. "We are extremely pleased to ... Directors.  With experience, vision and proven strength in leadership and ... important role in the company," said Pierre Lapalme, Chairman of ...
Cached Medicine Technology:Corgenix Reports Fiscal 2010 Financial Results 2Corgenix Reports Fiscal 2010 Financial Results 3BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors 2BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors 3
(Date:10/30/2014)... Five months after their expansion, the ... new branding and a website to accompany their recent ... Mepham’s promotion to name partner earlier this year, Hodgkinson ... Mepham’s name and better reflect their combined litigation expertise. ... decision to implement new branding reflects Hodgkinson Street Mepham’s ...
(Date:10/30/2014)... CT (PRWEB) October 30, 2014 Radio ... are raising questions about the impact of traditional radio ... marketing method most likely to influence a purchasing decision. ... poll of 525 consumers conducted by radio marketing company ... product categories, isolating the results of respondents who indicated ...
(Date:10/30/2014)... Dennis Thompson HealthDay ... The Ebola outbreak in Liberia -- one of three West ... World Health Organization officials said Wednesday. Dr. Bruce Aylward, ... the number of burials in Liberia and no increase in ... global push to tame the epidemic may be making some ...
(Date:10/30/2014)... 30, 2014 Horse Sense & ... riding to special needs individuals in the Jacksonville area, ... November 15 from 10-2:00 p.m. at Bailey's Farm (2202 ... to the public and is designed to raise awareness ... to the HSS Round-Up is free. Ticket purchases will ...
(Date:10/30/2014)... (PRWEB) October 30, 2014 REV'D Provision ... are now available through a unique service called, ... designed to empower the everyday athlete. The Feed has ... athletes and created a system to pass that information ... see REV’D® is now available on The Feed!” says ...
Breaking Medicine News(10 mins):Health News:Hodgkinson Street Mepham Rebrands 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 2Health News:CRN Research On Radio Messaging Effectiveness Now Available In Four Specific Product Categories 3Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 2Health News:Ebola Outbreak in Liberia May Be Slowing: WHO 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:Nutrition Experts at TheFeed.com Get REV'D 2Health News:Nutrition Experts at TheFeed.com Get REV'D 3
... MONICA, Calif., Feb. 3 The most common New ... on,physical appearance: lose weight, tone up, exercise more, and ... finding an intimate relationship,between body and mind. In order ... to maintain mental health and cognitive function as well ...
... 3 The US market for the drug treatment of ... to US Cancer Pain, a report released today by WWMR, ... a trend expected to continue throughout the next decade. ... primary driver of market value during the forecast period. ...
... CDC reports decline in two-thirds of the country, , , TUESDAY, ... decade in nearly two-thirds of the states, according to a ... Prevention. , The CDC,s data analysis showed that mammography use ... including Minnesota, Tennessee, Georgia and Alabama. But it fell by ...
... play a critical role in world,s largest global ... coming months, hundreds of Rotary club members from ... the United Kingdom and the Caribbean will join ... and health workers to immunize children against polio ...
... Breakthrough findings contribute to better understanding of little-known disease ... Feb. 3 A new research study has identified ... primary torsion dystonia (DYT6 type) in Amish-Mennonite families and ... that THAP1 causes dystonia in other ethnic groups.A paper ...
... Texas, Feb. 3 UpSpring Baby (TM) today ... breast milk is now available for purchase over-the-counter at ... is the nation,s largest drugstore chain and the first ... test. Milkscreen is also available for purchase through ...
Cached Medicine News:Health News:Dakim Recommends Six New Year Resolutions to Stay Cognitively Fit 2Health News:US Cancer Pain Market to Reach $5 Billion by 2018 - Cancer Patient Growth Drives Value 2Health News:US Cancer Pain Market to Reach $5 Billion by 2018 - Cancer Patient Growth Drives Value 3Health News:Fewer Women Are Having Mammograms 2Health News:Rotary Members Worldwide Prepare For Mass Immunization Campaigns In Polio-Endemic Countries 2Health News:Rotary Members Worldwide Prepare For Mass Immunization Campaigns In Polio-Endemic Countries 3Health News:The Bachmann-Strauss Dystonia & Parkinson Foundation: New Study Identifies Gene Mutations as Cause of Dystonia in Amish-Mennonite Families 2Health News:Milkscreen Home Test for Alcohol in Breast Milk Begins Nationwide Sales at Walgreens 2
... This "natural" Stereotest consists of three test plates(6mm, ... measurements in a range of 600 - 15 ... shape can only be detected if stereopsis is ... the risk of the patient learning the correct ...
... is designed to assist patients with red-green color ... filter cuts off wavelengths shorter than 582 nm ... of their most difficult color distinctions. A color ... determine whether a color is in the longer ...
Maxi-Lite diagnostic penlight features a twist-on backswitch....
Heavy duty, all purpose illuminator available in black only. Unique Clip Switch automatically turns off when returned to pocket. Pre-focused lens tip Heine XHL Halogen bulb for bright, concentrated l...
Medicine Products: